PMC:7600245 / 21030-21246
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T95 | 121-131 | Body_part | denotes | intestinal | http://purl.org/sig/ont/fma/fma7199 |
| T96 | 181-186 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T195 | 121-131 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestinal |
| T196 | 121-131 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestinal |
| T197 | 181-186 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T280 | 26-33 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
| T281 | 58-65 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T154 | 0-216 | Sentence | denotes | The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity of targeting the infected cells, and intracellular half-life. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 581 | 172-180 | Disease | denotes | infected | MESH:D007239 |